ELOXX PHARMACEUTICALS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $40.00K.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $17.00K, a 240.00% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $6.00K.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $5.00K, a 82.14% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $23.00K, a 67.61% decline from fiscal 2020.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $71.00K, a 57.99% decline from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $169.00K, a 62.11% decline from fiscal 2018.
- ELOXX PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $446.00K, a 2523.53% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $40.00K S-1 · filed 2026-09-11 | |
| 2021-12-31 | $23.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $17.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $6.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $71.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $5.00K 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $64.00K 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $169.00K 10-K · filed 2022-03-30 | |
| 2019-09-30 | $28.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $90.00K 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $25.00K 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $446.00K 10-K · filed 2021-03-12 | |
| 2018-09-30 | $6.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $97.00K 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $17.00K 10-K · filed 2020-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |